Adragos Pharma is a global CDMO headquartered in Munich, Germany. With production sites in Germany, France, Norway, Switzerland, Greece, and Japan, the company focuses on finished dosage form production in the small molecule space. The sites cover relevant technologies in sterile and non-sterile liquids and semisolids, providing end-to-end services for a large base of pharma customers.